SHOPPING: Shedding unwanted pounds no longer has to be a challenge thanks to this affordable alternative to Ozempic that's ...

Semaglutide and similar peptide drugs bind the G-protein coupled GLP-1 receptor to transfer chemical signals from outside the ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

With near infinite information available in our palms, finding the truth is still very hard. Just this morning, I had the ...

Nutritional approaches featuring reduced carbohydrates alongside elevated protein and fibre content trigger the release of ...

Eli Lilly will raise UK prices of its weight-loss and diabetes drug Mounjaro by up to 170 per cent from September, targeting ...

Cryotherapy, infant stem cells, extreme cold, IV infusions, red light therapy … more people are paying big bucks to buy into a "longevity" industry — and that has some traditional doctors worried.

The study also noted a 15% drop in substance misuse and showed benefit for patients who were taking stimulant medications rather than nonstimulants. Plus: developing new painkillers; how semaglutide ...

The US drug wholesaling industry is stable post-opioid settlement, with focus shifting to fund management and pharmacy ...

Ozempic and drugs like it have done wonders for weight loss by mimicking the natural hormone GLP-1 ( glucagon-like peptide-1 ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.